IDB Holland


Branche
Life Science & Health Care
Abschluss
2016
Käufer / Investor / Target
Advanced Accelerator Applications
Mandat
Verkauf
Kurzbeschreibung

DEX international M&A advised IDB Holland on the sale to Advanced Accelerator Applications. Advanced Accelerator Applications S.A. from New York (Nasdaq: AAAP), an international specialist in Molecular Nuclear Medicine announced today that it has acquired 100% of the shares of the IDB Group. The IDB Group is a leading manufacturer of Lutetium 177 (Lu-177).